New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Scientists identify new therapeutic target for metastatic cancer

Scientists identify new therapeutic target for metastatic cancer

by Katie Neith,City of Hope National Medical CenterCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.112971In a recent study led by Lei Jiang, Ph.D., an assistant professor of mo
World medicine December 10,2023
Scientists identify new therapeutic target for metastatic cancer

Scientists identify new therapeutic target for metastatic cancer

by Katie Neith,City of Hope National Medical CenterCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.112971In a recent study led by Lei Jiang, Ph.D., an assistant professor of mo
World medicine December 10,2023
Study shows cancers with high levels of the SLC7A11 gene may respond to glucose transporter inhibitor treatment

Study shows cancers with high levels of the SLC7A11 gene may respond to glucose transporter inhibitor treatment

byUniversity of Texas M. D. Anderson Cancer CenterKiller T cells surround a cancer cell. Credit: NIHNew findings from researchers at The University of Texas MD Anderson Cancer Center about how s
World medicine December 10,2023
Study shows cancers with high levels of the SLC7A11 gene may respond to glucose transporter inhibitor treatment

Study shows cancers with high levels of the SLC7A11 gene may respond to glucose transporter inhibitor treatment

byUniversity of Texas M. D. Anderson Cancer CenterKiller T cells surround a cancer cell. Credit: NIHNew findings from researchers at The University of Texas MD Anderson Cancer Center about how s
World medicine December 10,2023
Scientists discover innate tumor suppression mechanism

Scientists discover innate tumor suppression mechanism

byThe Wistar InstituteCredit: Pixabay/CC0 Public DomainThe p53 gene is one of the most important in the human genome: the only role of the p53 protein that this gene encodes is to sense when a t
World medicine December 10,2023
Scientists discover innate tumor suppression mechanism

Scientists discover innate tumor suppression mechanism

byThe Wistar InstituteCredit: Pixabay/CC0 Public DomainThe p53 gene is one of the most important in the human genome: the only role of the p53 protein that this gene encodes is to sense when a t
World medicine December 10,2023
Majority of patients responded in CAR T-cell trial for mantle cell lymphoma

Majority of patients responded in CAR T-cell trial for mantle cell lymphoma

byUniversity of Texas M. D. Anderson Cancer CenterKiller T cells surround a cancer cell. Credit: NIHA one-year follow-up study led by The University of Texas MD Anderson Cancer Center revealed a
World medicine December 10,2023
Majority of patients responded in CAR T-cell trial for mantle cell lymphoma

Majority of patients responded in CAR T-cell trial for mantle cell lymphoma

byUniversity of Texas M. D. Anderson Cancer CenterKiller T cells surround a cancer cell. Credit: NIHA one-year follow-up study led by The University of Texas MD Anderson Cancer Center revealed a
World medicine December 10,2023
Study shows recurrent alterations in prostate cancer in Chinese patients differ from those in the west

Study shows recurrent alterations in prostate cancer in Chinese patients differ from those in the west

by Bob Yirka , Medical XpressKiller T cells surround a cancer cell. Credit: NIHA very large team of researchers affiliated with institutions across China (and several from Washington University School
World medicine December 10,2023
Study shows recurrent alterations in prostate cancer in Chinese patients differ from those in the west

Study shows recurrent alterations in prostate cancer in Chinese patients differ from those in the west

by Bob Yirka , Medical XpressKiller T cells surround a cancer cell. Credit: NIHA very large team of researchers affiliated with institutions across China (and several from Washington University School
World medicine December 10,2023
Scientists uncover the 'Rosetta stone' of sarcoma research to personalize treatment

Scientists uncover the 'Rosetta stone' of sarcoma research to personalize treatment

byInstitute of Cancer ResearchKaposi sarcoma (cropped image). Credit:Yale Rosen,CC BY-SA 2.0Scientists have unveiled the first and largest encyclopedia of protein alterations in soft
World medicine December 10,2023
Scientists uncover the 'Rosetta stone' of sarcoma research to personalize treatment

Scientists uncover the 'Rosetta stone' of sarcoma research to personalize treatment

byInstitute of Cancer ResearchKaposi sarcoma (cropped image). Credit:Yale Rosen,CC BY-SA 2.0Scientists have unveiled the first and largest encyclopedia of protein alterations in soft
World medicine December 10,2023
Scientists find evidence of unintended impacts from anti-cancer drugs

Scientists find evidence of unintended impacts from anti-cancer drugs

byStowers Institute for Medical ResearchFluorescent image showing cells with normal nucleoli (bright orange) in nuclei (purple) surrounded by actin filaments (dark blue). Credit: Tamara Potapova
World medicine December 10,2023
Scientists find evidence of unintended impacts from anti-cancer drugs

Scientists find evidence of unintended impacts from anti-cancer drugs

byStowers Institute for Medical ResearchFluorescent image showing cells with normal nucleoli (bright orange) in nuclei (purple) surrounded by actin filaments (dark blue). Credit: Tamara Potapova
World medicine December 10,2023
Lung cancer trials supported by drug industry stronger

Lung cancer trials supported by drug industry stronger

by International Association for the Study of Lung CancerLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaLung cancer clinical trials supported by the pharmaceutical indu
World medicine December 10,2023
Lung cancer trials supported by drug industry stronger

Lung cancer trials supported by drug industry stronger

by International Association for the Study of Lung CancerLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaLung cancer clinical trials supported by the pharmaceutical indu
World medicine December 10,2023
Scientists identify immune cells critical for immunologic memory for melanoma

Scientists identify immune cells critical for immunologic memory for melanoma

by Yale Cancer CenterCredit: Pixabay/CC0 Public DomainImmune-checkpoint inhibitors have become the standard of care for patients with advanced melanoma to improve survival, but only some patients resp
World medicine December 10,2023
Scientists identify immune cells critical for immunologic memory for melanoma

Scientists identify immune cells critical for immunologic memory for melanoma

by Yale Cancer CenterCredit: Pixabay/CC0 Public DomainImmune-checkpoint inhibitors have become the standard of care for patients with advanced melanoma to improve survival, but only some patients resp
World medicine December 10,2023
Team develops novel radiopharmaceutical for the diagnosis of tumor-relevant transport proteins

Team develops novel radiopharmaceutical for the diagnosis of tumor-relevant transport proteins

byHelmholtz Association of German Research Centres(From left): Dr. Daniel Gündel, Dr. Masoud Sadeghzadeh, Dr. Magali Toussaint, Dr. Barbara Wenzel, Dr. Winnie Deuther-Conrad, Dr. Rares-Petru Mol
World medicine December 10,2023
Team develops novel radiopharmaceutical for the diagnosis of tumor-relevant transport proteins

Team develops novel radiopharmaceutical for the diagnosis of tumor-relevant transport proteins

byHelmholtz Association of German Research Centres(From left): Dr. Daniel Gündel, Dr. Masoud Sadeghzadeh, Dr. Magali Toussaint, Dr. Barbara Wenzel, Dr. Winnie Deuther-Conrad, Dr. Rares-Petru Mol
World medicine December 10,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com